Topic teaching: Drug-induced hemolytic anemia

Presented by

Dr. Sue Johnson
Director of Clinical Education
Director, Specialist in Blood Banking (SBB) Program
Versity

Learning objectives

1. List pretransfusion test results (antibody detection test/screen, direct antiglobulin test and eluate) consistent with drug-induced Immune hemolytic anemia.
2. Discuss categories of drug-induced immune hemolytic anemia (DIIHA).
3. Distinguish drug-dependent antibodies from warm or cold autoantibodies using patient clinical and medication history to determine dosage and timing of drug in relation to patient hemolysis.
4. Describe testing performed to confirm drug-dependent antibody.
5. List the most common drugs causing DIIHA.

Note: The session is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada.

Registration

Closed

Appraisal

Click here

To be added to the distribution list for the LearnTransfusion series, send an email to learn.transfusion@blood.ca  with “Weekly Transfusion Medicine Seminars” in the subject line. Include your name and complete e-mail address in the body of the e-mail and confirm that you would like to be added to the distribution list for the LearnTransfusion series. You will then receive weekly email notifications of upcoming series events with details on how to join the webinars (e.g.,  link to register for the webinar).

The LearnTransfusion series is the seminar component of the Areas of Focused Competency (AFC)-Diploma Program in Transfusion Medicine. The series, organized by Canadian Blood Services, is also open to all practitioners in the field of Transfusion Medicine. Through a series of regular webinars, trainees and practitioners are exposed to various scientific, technical and clinical aspects of transfusion medicine.